[1]
So, W. et al. 2018. INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB. Mediterranean Journal of Hematology and Infectious Diseases. 10, 1 (May 2018), e2018029. DOI:https://doi.org/10.4084/mjhid.2018.029.